Andrew Haughian
General Partner @ Pangaea Ventures
Vancouver, Canada
Andrew Haughian is a seed investor at Pangaea Ventures in Vancouver focused on Biotechnology and Medical. Andrew Haughian has over 12 years of energy and industrial experience. Andrew began his career in the upstream oil and gas industry before transitioning into engineering risk management consulting with a focus on the mining and forestry industries. Recently, Andrew has led several of Pangaea’s investments in the energy generation, energystorage and energy efficiency domains. Andrew holds a Bachelor of Applied Science (Mechanical Engineering) from the University of Toronto and a Masters in Business Administration degree from the Sauder School of Business at the University of British Columbia.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Andrew Haughian invests in
Stages Andrew Haughian invests in
Countries Andrew Haughian invests in
Investment Focus
Industry
- Biotechnology 2 (50%)
- Medical 1 (25%)
- 3D Printing 1 (25%)
- Health Care 1 (25%)
- Restaurants 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
- Funding Round 1 (25%)
Country
- United States 2 (50%)
- Canada 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aspect Biosystems
|
Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect’s microfluidic 3D bioprinting platform and collaborating within Aspect’s network, researchers worldwide are accelerating the development andcommercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on metabolic diseases and musculoskeletal injuries and disorders and partnering with key industry players to bring bioprinted therapeutics to the clinic. | $115M / Series B / Jan 08, 2025 | |
Prime Roots
|
Feeding people and the planet with 100% plant-based powerhouse protein! Joshua Nixon and Kimberlie Le founded Terramino in 2017 that later became Prime Roots. It has its headquarters in Berkeley, California. | $14M / Series A / Jul 06, 2020 | |
|
Aspect Biosystems
|
Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect’s microfluidic 3D bioprinting platform and collaborating within Aspect’s network, researchers worldwide are accelerating the development andcommercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on metabolic diseases and musculoskeletal injuries and disorders and partnering with key industry players to bring bioprinted therapeutics to the clinic. | Sep 18, 2017 | |
RSI (Reel Solar Inc)
|
RSI provides technology, tools, materials and know-how to the leaders in photovoltaic manufacturing. The company has developed a proprietary process for Rapid Efficient Electroplating on Large-areas (REEL). RSI works with regional manufacturing partners to deliver the lowest cost locally manufactured photovoltaic modules. The company was founded in2009 by a team of capital equipment veterans based in Silicon Valley, California. Co-investors include CalCEF Angel Fund, CMEA, Mayfield Fund, Nth Power, and Pangaea Ventures. | $4M / Seed |
Co-Investors
About Pangaea Ventures
Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor
Pangaea Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Erickson
General Partner
|
|||
Matthew Cohen
Associate
|
|||
Purnesh Seegopaul
General Partner
|
|||
Tracy Hedberg
Director, Finance and Administration
|
|||
|
Andrew Haughian
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Andrew Haughian invest in?
Andrew Haughian invests primarily in Biotechnology, Medical and 3D Printing startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrew Haughian last invest?
The most recent investment recorded for Andrew Haughian closed in Jan 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
